US Patent 11939383 B7-H4 antibodies and methods and use thereof
Patent 11939383 was granted and assigned to Five Prime Therapeutics on March, 2024 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11939383 B7-H4 antibodies and methods and use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.